Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.00
Bid: 325.50
Ask: 330.00
Change: 28.00 (9.33%)
Spread: 4.50 (1.382%)
Open: 304.00
High: 350.00
Low: 303.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Citigroup prefers Beazley over Hiscox and Lancashire

Thu, 15th Jul 2021 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday afternoon and Thursday morning:

----------

FTSE 100

----------

UBS RAISES HALMA PRICE TARGET TO 3,150 (3,000) PENCE - 'BUY'

----------

UBS RAISES BAE SYSTEMS PRICE TARGET TO 565 (516) PENCE - 'NEUTRAL'

----------

UBS RAISES COMPASS GROUP PRICE TARGET TO 1,550 (1,490) PENCE - 'NEUTRAL'

----------

CITIGROUP RAISES ENTAIN PRICE TARGET TO 2,200 (1,590) PENCE - 'BUY'

----------

CITIGROUP RAISES NATWEST PRICE TARGET TO 265 (250) PENCE - 'BUY'

----------

CITIGROUP CUTS STANDARD CHARTERED PRICE TARGET TO 490 (570) PENCE - 'NEUTRAL'

----------

CITIGROUP CUTS BARCLAYS PRICE TARGET TO 175 (180) PENCE - 'NEUTRAL'

----------

CITIGROUP CUTS HSBC PRICE TARGET TO 480 (490) PENCE - 'BUY'

----------

BERENBERG RAISES ADMIRAL GROUP PRICE TARGET TO 2,938 (2,758) PENCE - 'HOLD'

----------

PMORGAN CUTS AVIVA PRICE TARGET TO 498 (510) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES BARRATT DEVELOPMENTS TARGET TO 860 (850) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RAISES BARRATT PRICE TARGET TO 861 (821) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES COCA-COLA HBC PRICE TARGET TO 3,100 (3,000) PENCE - 'BUY'

----------

FTSE 250

----------

UBS CUTS ROTORK PRICE TARGET TO 365 (370) PENCE - 'NEUTRAL'

----------

UBS CUTS MEGGITT PRICE TARGET TO 473 (491) PENCE - 'NEUTRAL'

----------

UBS RAISES SPECTRIS PRICE TARGET TO 2,750 (2,700) PENCE - 'SELL'

----------

JPMORGAN RAISES SPECTRIS PRICE TARGET TO 2,900 (2,800) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES DUNELM GROUP PRICE TARGET TO 1,246 (1,215) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS ASHMORE GROUP PRICE TARGET TO 385 (405) PENCE - 'UNDERWEIGHT'

----------

GOLDMAN SACHS RAISES ROYAL MAIL PRICE TARGET TO 685 (600) PENCE - 'BUY'

----------

BERENBERG RAISES TULLOW OIL PRICE TARGET TO 50 (45) PENCE - 'HOLD'

----------

CITIGROUP INITIATES LANCASHIRE HOLDINGS WITH 'NEUTRAL' - TARGET 648 PENCE

----------

CITIGROUP INITIATES HISCOX WITH 'NEUTRAL' - TARGET 910 PENCE

----------

CITIGROUP INITIATES BEAZLEY WITH 'BUY'

----------

LIBERUM RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,560 (1,330) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

CITIGROUP RAISES GAMMA COMMUNICATIONS TARGET TO 2,000 (1,600) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES DARKTRACE PRICE TARGET TO 700 (580) PENCE - 'BUY'

----------

BERENBERG RAISES DARKTRACE PRICE TARGET TO 750 (525) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 May 2021 09:35

BROKER RATINGS: Royal Mail boosted to Buy from Hold by Peel Hunt

BROKER RATINGS: Royal Mail boosted to Buy from Hold by Peel Hunt

Read more
25 May 2021 08:22

LONDON BRIEFING: Shaftesbury seeing new demand for space in West End

LONDON BRIEFING: Shaftesbury seeing new demand for space in West End

Read more
21 May 2021 17:17

DIRECTOR DEALINGS: PageGroup CEO and Schroder chair sell shares

DIRECTOR DEALINGS: PageGroup CEO and Schroder chair sell shares

Read more
20 May 2021 16:07

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
18 May 2021 17:00

LONDON MARKET CLOSE: Sterling strengthens after solid UK jobless data

LONDON MARKET CLOSE: Sterling strengthens after solid UK jobless data

Read more
18 May 2021 12:12

LONDON MARKET MIDDAY: FTSE 100 higher as pound breaks through USD1.42

LONDON MARKET MIDDAY: FTSE 100 higher as pound breaks through USD1.42

Read more
18 May 2021 11:52

Oxford Biomedica jumps after AstraZeneca orders more Covid-19 vaccines

Oxford Biomedica jumps after AstraZeneca orders more Covid-19 vaccines

Read more
18 May 2021 09:23

UPDATE 2-FTSE 100 flat as Vodafone loss offsets gains in banks; Oxford Biomedica shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Oxford Biomedica rises on robust outlook* Vodafone drops after missing earnings expectations* FTSE 100 up 0.2%, FTSE 250 adds 0.6% (Update...

Read more
18 May 2021 08:45

LONDON MARKET OPEN: Stocks jump and pound heads towards USD1.42 mark

LONDON MARKET OPEN: Stocks jump and pound heads towards USD1.42 mark

Read more
18 May 2021 08:13

Oxford Biomedica ups revenue forecast as AstraZeneca lifts vaccine output

(Sharecast News) - Gene and cell therapy group Oxford Biomedica on Tuesday doubled annual earnings guidance after pharmaceutical giant AstraZeneca ordered more Covid-19 vaccines.

Read more
18 May 2021 07:47

LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale

LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale

Read more
28 Apr 2021 09:23

UPDATE 2-EU demands immediate access to UK-made vaccines in AstraZeneca legal battle

* EU demands faster deliveries in first hearing of legal case* AstraZeneca says lower supplies not in breach of contract* EU, UK vie for doses, Astra has under-delivered to both* Next hearings on May 26, EU seeks verdict before end of June (recast...

Read more
16 Apr 2021 09:49

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

Read more
15 Apr 2021 09:02

Oxford Biomedica swings to EBITDA profit

(Sharecast News) - Oxford Biomedica reported a 37% improvement in total revenues in its preliminary results on Thursday, to £87.7m.

Read more
15 Apr 2021 09:00

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.